Physical Activity — Program Evaluation of an In-school Daily Physical Activity Initiative
Citation(s)
Ahn S, Fedewa AL A meta-analysis of the relationship between children's physical activity and mental health. J Pediatr Psychol. 2011 May;36(4):385-97. doi: 10.1093/jpepsy/jsq107. Epub 2011 Jan 11.
Anderson-Butcher D, Conroy DE Factorial and Criterion Validity of Scores of a Measure of Belonging in Youth Development Programs. Educ Psychol Meas. 2002;62:857-76.
Bandura A Guide for constructing self-efficacy scales. Self-Effic Beliefs Adolesc. 2006;5.
Crocker PR, Bailey DA, Faulkner RA, Kowalski KC, McGrath R Measuring general levels of physical activity: preliminary evidence for the Physical Activity Questionnaire for Older Children. Med Sci Sports Exerc. 1997 Oct;29(10):1344-9.
Duckworth AL, Quinn PD Development and validation of the short grit scale (grit-s). J Pers Assess. 2009 Mar;91(2):166-74. doi: 10.1080/00223890802634290.
Goodman R, Meltzer H, Bailey V The Strengths and Difficulties Questionnaire: a pilot study on the validity of the self-report version. Int Rev Psychiatry. 2003 Feb-May;15(1-2):173-7.
Janssen I, Leblanc AG Systematic review of the health benefits of physical activity and fitness in school-aged children and youth. Int J Behav Nutr Phys Act. 2010 May 11;7:40. doi: 10.1186/1479-5868-7-40.
Lyubomirsky S, Lepper HS A measure of subjective happiness: Preliminary reliability and construct validation. Soc Indic Res. 1999;46:137-155.
Moilanen KL The Adolescent Self-Regulatory Inventory: The development and validation of a questionnaire of short-term and long-term self-regulation. J Youth Adolesc. 2007;36:835-48.
Muris P, Meesters C, Eijkelenboom A, Vincken M The self-report version of the Strengths and Difficulties Questionnaire: its psychometric properties in 8- to 13-year-old non-clinical children. Br J Clin Psychol. 2004 Nov;43(Pt 4):437-48.
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
